Asia Pacific Knee Cartilage Repair Market
Taille du marché en milliards USD
TCAC :
% 
 Période de prévision |
2024 –2030 |
 Taille du marché (année de référence) |
|
 Taille du marché (année de prévision) |
|
 TCAC |
% |
| Principaux acteurs du marché |
>Marché de la réparation du cartilage du genou en Asie-Pacifique, par produit (à base de cellules et non à base de cellules), modalité (transplantation ostéochondrale, microfracture, arthroplastie par abrasion, forage, implantation de chondrocytes et autres), type de cartilage (cartilage hyalin et fibrocartilage), application (arthrose, polyarthrite rhumatoïde , sténoses, fractures, tumeurs osseuses et autres), utilisateur final (hôpitaux, centres de chirurgie ambulatoire, cliniques spécialisées, instituts de recherche et universitaires et autres), canal de distribution (ventes directes, distributeur tiers, ventes en ligne et autres), tendances de l'industrie et prévisions jusqu'en 2030.
Analyse et perspectives du marché de la réparation du cartilage du genou en Asie-Pacifique
Les lancements de produits devraient favoriser la croissance des industries afin d'augmenter les ventes et la distribution de produits de réparation du cartilage du genou pour les troubles du genou. Le lancement du produit générera de nouveaux partenariats et collaborations commerciales. Le lancement permettrait aux clients d'acheter le nouveau produit qui leur est proposé. Les lancements sont susceptibles de refléter une tendance positive dans la croissance du marché.
En outre, l'augmentation de l'incidence des maladies du genou, l'augmentation de la population gériatrique, la sensibilisation accrue au traitement du genou en Asie-Pacifique et les développements technologiques dans les dispositifs de réparation du cartilage du genou devraient stimuler la croissance du marché. Les initiatives stratégiques prises par les principaux acteurs du marché stimulent également la croissance du marché au cours de la période prévue.
Cependant, le coût élevé des chirurgies du genou et les problèmes rencontrés lors de l’utilisation de l’orthopédie du genou devraient freiner la croissance du marché.
Data Bridge Market Research analyse que le marché de la réparation du cartilage du genou en Asie-Pacifique connaîtra un TCAC de 11,1 % au cours de la période de prévision de 2023 à 2030.
|
Rapport métrique |
Détails |
|
Période de prévision |
2023 à 2030 |
|
Année de base |
2022 |
|
Années historiques |
2021 (personnalisable pour 2020-2016) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, volumes en unités, prix en USD |
|
Segments couverts |
Par produit (à base de cellules et non à base de cellules), modalité (transplantation ostéochondrale, microfracture, arthroplastie par abrasion, forage, implantation de chondrocytes et autres), type de cartilage (cartilage hyalin et fibrocartilage), application (arthrose, polyarthrite rhumatoïde, sténoses, fractures, tumeurs osseuses et autres), utilisateur final (hôpitaux, centres de chirurgie ambulatoire , cliniques spécialisées, instituts de recherche et universitaires et autres), canal de distribution (ventes directes, distributeur tiers, ventes en ligne et autres). |
|
Pays couverts |
Japon, Chine, Corée du Sud, Inde, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines, Vietnam et reste de l'Asie-Pacifique. |
|
Acteurs du marché couverts |
Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (une filiale de Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (une filiale de Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi et Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, entre autres |
Définition du marché :
Le genou est la plus grosse articulation du corps. Les os supérieurs et inférieurs du genou sont séparés par deux disques (ménisques). L'os supérieur de la jambe (fémur) et les os inférieurs de la jambe (tibia et péroné) sont reliés par des ligaments et des tendons. Le cartilage est le type de tissu conjonctif le plus courant. On le trouve sous diverses formes dans nos articulations, notre colonne vertébrale, nos os, nos oreilles, nos poumons et notre nez. Le cartilage est un tissu conjonctif flexible qui recouvre les surfaces des os de nos articulations et les protège contre les chocs pour maintenir la mobilité articulaire.
La réparation du cartilage du genou est une procédure qui consiste à réparer le cartilage endommagé tout en lissant la surface restante du tissu. La chirurgie de réparation du cartilage, qui tente de restaurer le tissu cartilagineux et sa fonction pour éviter l'arthrose à long terme, est un choix de traitement approprié pour les anomalies focales du cartilage de pleine épaisseur du genou. L'ostéotomie, le remplacement du genou et la microfracture sont quelques-unes des techniques de réparation du cartilage du genou les plus courantes. Les techniques chirurgicales ou les procédures chirurgicales moins courantes, telles que la transplantation ostéochondrale d'allogreffe, l'implantation de chondrocytes autologues et les échafaudages artificiels, sont parfois utilisées pour réparer les lésions du cartilage.
Dynamique du marché de la réparation du cartilage du genou en Asie-Pacifique
Conducteurs
-
AUGMENTATION DE LA PRÉVALENCE DES TROUBLES DU GENOU
Le trouble articulaire le plus courant chez les personnes âgées est l'arthrose du genou (AO), où la destruction et la perte du cartilage articulaire sont une caractéristique centrale de la plupart des formes d'arthrite, y compris la forme la plus courante qui est l'arthrose. Dans l'arthrose, le cartilage d'une articulation commence à se dégrader et l'os sous-jacent se modifie. Cela provoque non seulement des douleurs et des déficiences physiques chez les patients, mais impose également une charge de morbidité importante à l'ensemble de la population. Les années vécues avec incapacité (YLD) sont la mesure standard pour quantifier la charge de morbidité dans la plupart des maladies chroniques, telles que l'arthrose. Une année d'incapacité équivaut à une année de vie « saine » perdue. La somme des YLD dans la population, la charge de morbidité, représente la différence entre l'état de santé actuel et une situation de santé idéale dans laquelle l'ensemble de la population vivrait jusqu'à un âge avancé sans maladie ni incapacité. L'augmentation de l'incidence des troubles chroniques du genou devrait stimuler les ventes et l'approvisionnement de médicaments et d'implants pour le traitement des genoux en Asie-Pacifique. Elle devrait répondre aux besoins des patients. Les connaissances sur la prévalence et l'incidence des maladies orthopédiques du genou aideraient à trouver de nouvelles solutions et à favoriser davantage de collaborations et de partenariats avec les acteurs du marché basés dans les pays de la région Asie-Pacifique. Par conséquent, l'augmentation des troubles du genou devrait stimuler la croissance du marché.
-
AUGMENTATION DU NOMBRE D'OPÉRATIONS CHIRURGICALES DU GENOU
Les remplacements et les interventions chirurgicales de la hanche et du genou sont parmi les interventions les plus fréquentes et les plus efficaces en Asie-Pacifique. L'arthrose est la principale indication pour le remplacement et l'intervention chirurgicale de la hanche et du genou, car l'arthrose est également la cause de lésions cartilagineuses et de destruction du cartilage articulaire. Les interventions chirurgicales dues à l'arthrose impliquent donc également une réparation du cartilage. Les interventions chirurgicales du genou deviennent assez courantes en Asie-Pacifique en raison de la prévalence croissante des blessures au genou liées au sport et de l'élargissement des indications pour le remplacement total du genou en raison des préférences des patients et des chirurgiens.
L'augmentation du nombre d'opérations du genou dans les pays d'Asie-Pacifique permettrait de sensibiliser et de traiter rapidement les patients souffrant de morbidités chroniques du genou. Le développement technologique serait d'une importance cruciale dans le développement d'implants de genou avancés. Une optimisation supplémentaire et de nouveaux développements technologiques ouvriraient la voie à l'utilisation d'implants 3D. L'augmentation du nombre d'opérations du genou devrait stimuler la croissance du marché de la réparation du cartilage du genou en Asie-Pacifique.
Opportunités
-
SENSIBILISATION ACCRUE AU TRAITEMENT DU GENOU
Understanding knee disorders and the scope of the treatment is vital to help and guiding people suffering from osteoarthritis and meniscal injuries. It helps in achieving early detection and management. Awareness about the symptoms and treatment of chronic knee diseases by public and private institutes would result in timely treatment and provide access to inexpensive universal health aid along with increased availability of rehabilitative treatment. The Asia-Pacific Knee Society (APKS) was created to bring the key opinion leaders in the field of Asia-Pacific's degenerative knee and knee arthroplasty together and gather valuable information about growing trends and awareness.
The awareness about the early treatment and use of knee implants would result in collaborations of market players with health institutions to supply and distribute the devices. This will result in a rise in product and business line expansion. Hence, a rise in awareness among people about timely treatment is expected to act as an opportunity for market growth.
-
GROWING GERIATRIC POPULATION
Knee disorders, namely knee osteoarthritis, and ligament tears, are common in the elderly population in Asia-Pacific. Bone problems are likely to affect persons 60 years and older, especially those residing in long-term care institutions. As the elderly population ages, the prevalence of knee diseases may rise, opening the door for the development of drugs and implants in diagnostic and preventive methods vital for improving knee disorders in older persons. Along with other risk factors, the vulnerability to knee diseases also increases with age. Osteoarthritis of the knee can be brought on by injury, infection, or being overweight, or it might be inherited in certain people. Women are more likely to experience the same.
A type of connective tissue called cartilage can be found throughout the body. Despite being a strong and flexible material, it is relatively simple to harm. Additionally, the cartilage gradually deteriorates with age, and osteoarthritis sufferers frequently experience stiffness, especially after prolonged periods of sitting or lying down. The joints' capacity to withstand demands decreases as the body's natural shock absorbers deteriorate. With advancing age, bone density and muscle tone gradually deteriorate, making physically demanding occupations even more challenging. Therefore, the expanding elderly population experiences more bone and joint problems that require early treatment and are therefore anticipated to propel market expansion.
As the geriatric population increases and suffering from chronic knee increases, it would result in increased treatment demand. Therefore, the rise in the geriatric population is expected to boost the growth of the market.
Restraints/Challenges
- HIGH COST OF THE ORTHOPEDIC KNEE IMPLANTS AND SURGERIES
Knee arthroplasty is a popular procedure but exhibits a high cost. The cost of knee implants is due to technological development and the rising preference for less invasive orthopedic knee implants.
The cost of Autologous Chondrocyte Implantation (ACI) is expensive. Osteochondral allograft transplantation is a specialized procedure. Its cost is thus high depending upon the cost of the allografts. It ranges from around $10,000. Hence, it is expected to hamper the market growth.
Post-COVID-19 Impact on Asia-Pacific Knee Cartilage Repair Market
COVID-19 has negatively affected the market. Lockdowns and isolation during the pandemic complicate disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration has impacted the market.
Recent Development
- In March 2022, CritiCare Asia launched Cuvis 3rd Generation Robotic Arm Technology for joint replacement surgeries to enable surgeons to perform complex joint replacement surgeries precisely by overcoming the challenges they face during traditional open surgeries. This way, artificial intelligence aid the surgeries with minimally invasive.
Asia-Pacific Knee Cartilage Repair Market Scope
The Asia-Pacific knee cartilage repair market is categorized into six segments based on product, modality, cartilage type, application, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Cell-Based
- Non-Cell-Based
Based on product, the Asia-Pacific knee cartilage repair market is segmented into cell-based and non-cell-based.
Modality
- Osteochondral Transplantation
- Microfracture
- Abrasion Arthroplasty
- Drilling
- Chondrocyte Implantation
- Others
Based on modality, the Asia-Pacific knee cartilage repair market is segmented into chondrocyte implantation, microfracture, drilling, abrasion arthroplasty, osteochondral transplantation, and others.
Cartilage Type
- Hyaline Cartilage
- Fibrocartilage
Based on cartilage type, the Asia-Pacific knee cartilage repair market is segmented into hyaline cartilage and fibrocartilage.
Application
- Osteoarthritis
- Rheumatoid Arthritis
- Bone Tumors
- Fractures
- Steonecrosis
Based on application, the Asia-Pacific knee cartilage repair market is segmented into osteoarthritis, rheumatoid arthritis, bone tumors, fractures, and steonecrosis.
End User
- Hospital
- Ambulatory Surgical Centers
- Specialty Clinics
- Research And Academic Institutes
- Others
Based on end user, the Asia-Pacific knee cartilage repair market is segmented into hospital, ambulatory surgical centers, specialty clinics, research and academic institutes, and others.
Distribution Channel
- Direct Sales
- Third Party Distributor
- Online Sales
- Others
Based on distribution channel, Asia-Pacific knee cartilage repair market is segmented into direct sales, third party distributor, online sales, and others.
Asia-Pacific Knee Cartilage Repair Regional Analysis/Insights
The Asia-Pacific knee cartilage repair market is analyzed, and market size insights and trends are provided by country, product, modality, cartilage type, application, end user, and distribution channel, as referenced above.
The Asia-Pacific knee cartilage repair market is expected to grow due to an increase in cases of knee disorders and the growing geriatric population. The increasing risk of fractures related to osteoporosis and accident cases is also driving the market growth. In addition, rising initiatives by market players to launch advanced products in the region will further boost market growth in the forecast period.
China is expected to dominate the Asia-Pacific knee cartilage repair market due to advanced technology, the high prevalence of knee osteoarthritis, and an established healthcare system.
The country section of the report also provides individual market-impacting factors and changes in regulations in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of other brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Asia-Pacific Knee Cartilage Repair Market Share Analysis
The Asia-Pacific knee cartilage repair market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, country presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus related to the Asia-Pacific knee cartilage repair market.
Some of the major players operating in the Asia-Pacific knee cartilage repair market are Stryker, Zimmer Biomet, B. Braun Melsungen AG, Smith & Nephew, BioTissue, CONMED, DePuy Synthes Companies (A part of Johnson & Johnson Medical Devices Companies), Arthrex, Inc., Medacta International, Regrow Biosciences Pvt. Ltd., Regentis Biomaterials Ltd., Anika Therapeutics, Inc., Auxein Medical, BioGend Therapeutics Co., Ltd., CartiHeal, Inc. (A subsidiary of Bioventus Inc.), MEDIPOST, Sartorius CellGenix GmbH, Sanofi and Waldemar Link GmbH & Co. KG, Geistlich Pharma AG, among others.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 TREATMENT SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 MARKET APPLICATION COVERAGE GRID
2.1 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER'S FIVE FORCES MODEL
4.3 PATENT ANALYSIS
5 INDUSTRIAL INSIGHTS
6 EPIDEMIOLOGY
7 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, REGULATION
8 MARKET OVERVIEW
8.1 DRIVERS
8.1.1 INCREASE IN THE PREVALENCE OF KNEE DISORDERS
8.1.2 RISE IN THE NUMBER OF KNEE SURGERIES
8.1.3 GROWTH IN TECHNOLOGICAL ADVANCEMENTS
8.1.4 INCREASE IN DEMAND FOR MINIMALLY INVASIVE PROCEDURES
8.2 RESTRAINTS
8.2.1 HIGH COST OF THE ORTHOPEDIC KNEE IMPLANTS AND SURGERIES
8.2.2 RISE IN CONCERN REGARDING METAL SENSITIVITY IN PATIENTS WITH KNEE IMPLANTS
8.3 OPPORTUNITIES
8.3.1 RISE IN AWARENESS ABOUT KNEE TREATMENT
8.3.2 GROWING GERIATRIC POPULATION
8.3.3 HIGH PREVALENCE OF KNEE INJURIES
8.4 CHALLENGES
8.4.1 LACK OF SKILLED PROFESSIONALS
8.4.2 STRINGENT REGULATIONS
9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT
9.1 OVERVIEW
9.2 CELL BASED
9.2.1 CHONDROCYTE TRANSPLANTATION
9.2.2 STEM CELL
9.2.3 GROWTH FACTORS
9.3 NON-CELL BASED
9.3.1 TISSUE SCAFFOLDS
9.3.2 CELL-FREE COMPOSITES
10 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY
10.1 OVERVIEW
10.2 CHONDROCYTE IMPLANTATION
10.3 MICROFRACTURE
10.4 DRILLING
10.5 ABRASION ARTHROPLASTY
10.6 OSTEOCHONDRAL TRANSPLANTATION
10.7 OTHERS
11 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE
11.1 OVERVIEW
11.2 HYALINE CARTILAGE
11.3 FIBROCARTILAGE
12 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION
12.1 OVERVIEW
12.2 OSTEOARTHRITIS
12.3 RHEUMATOID ARTHRITIS
12.4 FRACTURES
12.5 BONE TUMORS
12.6 OSTEONECROSIS
12.7 OTHERS
13 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY END USER
13.1 OVERVIEW
13.2 HOSPITALS
13.2.1 BY TYPE
13.2.1.1 PRIVATE
13.2.1.2 PUBLIC
13.2.2 BY SIZE
13.2.2.1 LARGE
13.2.2.2 MEDIUM
13.2.2.3 SMALL
13.3 AMBULATORY SURGICAL CENTERS
13.4 SPECIALTY CLINICS
13.5 RESEARCH AND ACADEMIC INSTITUTES
13.6 OTHERS
14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT SALES
14.3 THIRD PARTY DISTRIBUTORS
14.4 ONLINE SALES
14.5 OTHERS
15 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY COUNTRY
15.1 CHINA
15.2 JAPAN
15.3 INDIA
15.4 SOUTH KOREA
15.5 AUSTRALIA
15.6 THAILAND
15.7 MALAYSIA
15.8 SINGAPORE
15.9 INDONESIA
15.1 VIETNAM
15.11 PHILIPPINES
15.12 REST OF ASIA-PACIFIC
16 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
17 SWOT ANALYSIS
18 COMPANY PROFILES
18.1 SANOFI
18.1.1 COMPANY SNAPSHOT
18.1.2 REVENUE ANALYSIS
18.1.3 RODUCT PORTFOLIO
18.1.4 RECENT DEVELOPMENT
18.2 ZIMMER BIOMET
18.2.1 COMPANY SNAPSHOT
18.2.2 REVENUE ANALYSIS
18.2.3 PRODUCT PORTFOLIO
18.2.4 RECENT DEVELOPMENTS
18.3 SMITH & NEPHEW
18.3.1 COMPANY SNAPSHOT
18.3.2 REVENUE ANALYSIS
18.3.3 PRODUCT PORTFOLIO
18.3.4 RECENT DEVELOPMENTS
18.4 STRYKER
18.4.1 COMPANY SNAPSHOT
18.4.2 REVENUE ANALYSIS
18.4.3 PRODUCT PORTFOLIO
18.4.4 RECENT DEVELOPMENTS
18.5 MEDIPOST
18.5.1 COMPANY SNAPSHOT
18.5.2 REVENUE ANALYSIS
18.5.3 PRODUCT PORTFOLIO
18.5.4 RECENT DEVELOPMENT
18.6 ARTHREX, INC.
18.6.1 COMPANY SNAPSHOT
18.6.2 PRODUCT PORTFOLIO
18.6.3 RECENT DEVELOPMENT
18.7 ANIKA THERAPEUTICS, INC.
18.7.1 COMPANY SNAPSHOT
18.7.2 REVENUE ANALYSIS
18.7.3 PRODUCT PORTFOLIO
18.7.4 RECENT DEVELOPMENT
18.8 AUXEIN MEDICAL
18.8.1 COMPANY SNAPSHOT
18.8.2 PRODUCT PORTFOLIO
18.8.3 RECENT DEVELOPMENTS
18.9 B. BRAUN MELSUNGEN AG
18.9.1 COMPANY SNAPSHOT
18.9.2 PRODUCT PORTFOLIO
18.9.3 RECENT DEVELOPMENTS
18.1 BIOGEND THERAPEUTICS CO., LTD.
18.10.1 COMPANY SNAPSHOT
18.10.2 PRODUCT PORTFOLIO
18.10.3 RECENT DEVELOPMENTS
18.11 BIOTISSUE
18.11.1 COMPANY SNAPSHOT
18.11.2 PRODUCT PORTFOLIO
18.11.3 RECENT DEVELOPMENT
18.12 CONMED
18.12.1 COMPANY SNAPSHOT
18.12.2 REVENUE ANALYSIS
18.12.3 PRODUCT PORTFOLIO
18.12.4 RECENT DEVELOPMENT
18.13 CARTIHEAL, INC. (A SUBSIDIARY OF BIOVENTUS INC.)
18.13.1 COMPANY SNAPSHOT
18.13.2 REVENUE ANALYSIS
18.13.3 PRODUCT PORTFOLIO
18.13.4 RECENT DEVELOPMENT
18.14 DEPUY SYNTHES COMPANIES (A PART OF JHONSON & JHONSON MEDICAL DEVICES COMPANIES)
18.14.1 COMPANY SNAPSHOT
18.14.2 REVENUE ANALYSIS
18.14.3 PRODUCT PORTFOLIO
18.14.4 RECENT DEVELOPMENT
18.15 GEISTLICH PHARMA AG
18.15.1 COMPANY SNAPSHOT
18.15.2 PRODUCT PORTFOLIO
18.15.3 RECENT DEVELOPMENTS
18.16 MEDACTA INTERNATIONAL
18.16.1 COMPANY SNAPSHOT
18.16.2 PRODUCT PORTFOLIO
18.16.3 RECENT DEVELOPMENT
18.17 REGENTIS BIOMATERIALS LTD.
18.17.1 COMPANY SNAPSHOT
18.17.2 PRODUCT PORTFOLIO
18.17.3 RECENT DEVELOPMENTS
18.18 REGROW BIOSCIENCES PVT LTD.
18.18.1 COMPANY SNAPSHOT
18.18.2 PRODUCT PORTFOLIO
18.18.3 RECENT DEVELOPMENTS
18.19 SARTORIUS CELLGENIX GMBH
18.19.1 COMPANY SNAPSHOT
18.19.2 PRODUCT PORTFOLIO
18.19.3 RECENT DEVELOPMENT
18.2 WALDEMAR LINK GMBH & CO. KG
18.20.1 COMPANY SNAPSHOT
18.20.2 PRODUCT PORTFOLIO
18.20.3 RECENT DEVELOPMENTS
19 QUESTIONNAIRE
20 RELATED REPORTS
Liste des tableaux
TABLE 1 NUMBER OF INDIVIDUALS AFFECTED BY METAL
TABLE 2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 3 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 4 ASIA-PACIFIC CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 ASIA-PACIFIC CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 6 ASIA-PACIFIC NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 ASIA-PACIFIC NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 8 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 10 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 11 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 12 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 13 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 15 ASIA-PACIFIC HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 ASIA-PACIFIC HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 17 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 18 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 19 CHINA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 20 CHINA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 21 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 22 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 23 CHINA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 24 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 25 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 26 CHINA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 27 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 28 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 29 CHINA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 30 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 31 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 32 CHINA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 33 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 34 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 35 CHINA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 36 CHINA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 37 CHINA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 38 CHINA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 39 CHINA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 40 JAPAN KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 41 JAPAN KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 42 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 43 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 44 JAPAN CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 45 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 46 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 47 JAPAN NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 48 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 49 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 50 JAPAN KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 51 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 52 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 53 JAPAN KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 54 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 55 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 56 JAPAN KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 57 JAPAN KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 58 JAPAN HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 59 JAPAN HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 60 JAPAN KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 61 INDIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 62 INDIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 63 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 64 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 65 INDIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 66 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 67 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 68 INDIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 69 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 70 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 71 INDIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 72 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 73 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 74 INDIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 75 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 76 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 77 INDIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 78 INDIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 79 INDIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 INDIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 81 INDIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 82 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 83 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 84 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 85 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 86 SOUTH KOREA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 87 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 88 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 89 SOUTH KOREA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 90 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 91 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 92 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 93 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 94 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 95 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 96 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 97 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 98 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 99 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 100 SOUTH KOREA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 SOUTH KOREA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 102 SOUTH KOREA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 103 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 104 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 105 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 107 AUSTRALIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 108 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 109 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 110 AUSTRALIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 111 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 112 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 113 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 114 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 115 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 116 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 117 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 118 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 119 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 120 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 AUSTRALIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 122 AUSTRALIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 123 AUSTRALIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 124 THAILAND KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 125 THAILAND KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 126 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 128 THAILAND CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 129 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 131 THAILAND NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 132 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 133 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 134 THAILAND KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 135 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 136 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 137 THAILAND KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 138 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 139 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 140 THAILAND KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 141 THAILAND KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 142 THAILAND HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 143 THAILAND HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 144 THAILAND KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 145 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 146 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 147 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 148 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 149 MALAYSIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 150 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 151 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 152 MALAYSIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 153 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 154 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 155 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 156 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 157 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 158 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 159 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 160 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 161 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 162 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 163 MALAYSIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 164 MALAYSIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 165 MALAYSIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 166 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 167 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 168 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 169 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 170 SINGAPORE CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 171 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 172 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 173 SINGAPORE NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 174 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 175 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 176 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 177 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 178 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 179 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 180 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 181 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 182 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 183 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 184 SINGAPORE HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 185 SINGAPORE HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 186 SINGAPORE KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 187 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 188 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 189 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 190 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 191 INDONESIA CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 192 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 193 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 194 INDONESIA NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 195 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 196 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 197 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 198 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 199 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 200 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 201 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 202 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 203 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 204 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 205 INDONESIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 206 INDONESIA HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 207 INDONESIA KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 208 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 209 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 210 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 211 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 212 VIETNAM CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 213 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 214 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 215 VIETNAM NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 216 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 217 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 218 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 219 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 220 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 221 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 222 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 223 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 224 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 225 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 226 VIETNAM HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 227 VIETNAM HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 228 VIETNAM KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 229 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 230 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
TABLE 231 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 232 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 233 PHILIPPINES CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 234 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 235 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (UNITS)
TABLE 236 PHILIPPINES NON-CELL BASED IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030, (ASP)
TABLE 237 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (USD MILLION)
TABLE 238 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (UNITS)
TABLE 239 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY MODALITY, 2021-2030 (ASP)
TABLE 240 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (USD MILLION)
TABLE 241 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030 (UNITS)
TABLE 242 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY CARTILAGE TYPE, 2021-2030, (ASP)
TABLE 243 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 244 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (UNITS)
TABLE 245 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY APPLICATION, 2021-2030 (ASP)
TABLE 246 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 247 PHILIPPINES HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 248 PHILIPPINES HOSPITALS IN KNEE CARTILAGE REPAIR MARKET, BY SIZE, 2021-2030 (USD MILLION)
TABLE 249 PHILIPPINES KNEE CARTILAGE REPAIR MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 250 REST OF ASIA PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC KNEE CARTILAGE REPAIR MARKET, BY PRODUCT, 2021-2030 (UNITS)
Liste des figures
FIGURE 1 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION
FIGURE 2 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DATA TRIANGULATION
FIGURE 3 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DROC ANALYSIS
FIGURE 4 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: DBMR POSITION GRID
FIGURE 8 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: APPLICATION COVERAGE GRID
FIGURE 9 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SEGMENTATION
FIGURE 10 INCREASE IN THE PREVALENCE OF KNEE DISORDERS AND A RISE IN THE NUMBER OF KNEE SURGERIES ARE EXPECTED TO DRIVE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET
FIGURE 11 CELL-BASED SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET FROM 2023 & 2030
FIGURE 12 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET
FIGURE 13 NUMBER OF TOTAL KNEE ARTHROPLASTIES FROM 2011-2019 IN CHINA
FIGURE 14 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, 2022
FIGURE 15 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, 2023-2030 (USD MILLION)
FIGURE 16 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, CAGR (2023-2030)
FIGURE 17 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT, LIFELINE CURVE
FIGURE 18 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, 2022
FIGURE 19 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, 2023-2030 (USD MILLION)
FIGURE 20 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, CAGR (2023-2030)
FIGURE 21 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY MODALITY, LIFELINE CURVE
FIGURE 22 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, 2022
FIGURE 23 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, 2023-2030 (USD MILLION)
FIGURE 24 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, CAGR (2023-2030)
FIGURE 25 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY CARTILAGE TYPE, LIFELINE CURVE
FIGURE 26 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, 2022
FIGURE 27 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, 2023-2030 (USD MILLION)
FIGURE 28 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, CAGR (2023-2030)
FIGURE 29 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 30 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, 2022
FIGURE 31 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 32 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, CAGR (2023-2030)
FIGURE 33 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 35 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 36 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 37 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: SNAPSHOT (2022)
FIGURE 39 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2022)
FIGURE 40 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2023 & 2030)
FIGURE 41 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY COUNTRY (2022 & 2030)
FIGURE 42 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: BY PRODUCT (2023-2030)
FIGURE 43 ASIA-PACIFIC KNEE CARTILAGE REPAIR MARKET: COMPANY SHARE 2022 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
